Instruction for use: Foradil

Active substance: Formoterol

ATX Code R03AC13 Formoterol

Pharmacotherapeutic group:

Beta2-agonists selective [beta-adrenergic agonist]

The nosological classification (ICD-10)

J42 Chronic bronchitis, unspecified

recurrent bronchitis, Bronchitis asthma, wheeze bronchitis, chronic Bronchitis, Inflammatory airways disease, bronchi disease, Qatar smoker, Cough in inflammatory diseases of the lung and bronchus, Exacerbation of Chronic Bronchitis, Chronic bronchitis, Chronic obstructive pulmonary disease, Chronical bronchitis, Chronic bronchitis smokers, Chronic spastic bronchitis, allergic Bronchitis

J43 Emphysema

Interstitial emphysema, Emphysema, Chronic lung disease, Chronic obstructive pulmonary disease, Obstructive pulmonary emphysema, Chronic pulmonary emphysema, Chronic obstructive pulmonary emphysema

J44 Other chronic obstructive pulmonary disease

Allergic bronchitis, Bronchitis asthma, Asthmatic bronchitis, wheeze bronchitis, Bronchitis is an obstructive, bronchi disease, Shortness of sputum in acute and chronic respiratory diseases, Cough in inflammatory diseases of the lung and bronchus, Reversible airflow obstruction, Reversible obstructive airway disease, Obstructive bronchitis disease, Obstructive lung disease, Obstructive bronchitis, Spastic bronchitis, Chronic lung disease, Chronic nonspecific lung diseases, Chronic obstructive pulmonary disease, Chronic obstructive bronchitis, Chronic obstructive airway disease, Chronic obstructive pulmonary disease, Restrictive lung pathology

J45 Asthma

Asthma physical effort, status asthmaticus, Bronchial asthma, Asthma lung flow, Bronchial asthma with obstruction of sputum discharge, Bronchial asthma heavy currents, Bronchial asthma physical effort, hypersecretory asthma, Hormone-dependent form of bronchial asthma, Relief of asthma attacks in bronchial asthma, Non-allergic asthma, nocturnal asthma, Exacerbation of asthma, Asthma attacks, Endogenous forms of asthma, Night asthma, Cough with bronchial asthma

J98.8.0 * Bronchospasm

Bronchospasm in bronchial asthma, Bronchospasm when exposed to an allergen, bronchospastic reactions, bronchospastic status, bronhospastichesky syndrome, Diseases accompanied by bronchospastic syndrome, reversible bronchospasm, spasmodic cough

Composition

Capsules with powder for inhalation 1 caps.

active substance:

formoterol fumarate 0.012 mg

excipient: lactose - 25 mg

Pharmacological Properties
Pharmachologic effect

bronchodilatory.

Dosing and Administration

Inhalation.

It is intended for inhalation use in adults and children 5 years and older. The preparation is not intended for ingestion.

Dose selected individually depending on the needs of the patient. It should use the lowest dose that provides a therapeutic effect. Upon reaching the control of asthma symptoms on a background therapy with Foradil, you should consider a gradual reduction in dose. Dose reduction is carried out under regular medical supervision of the patient.

The drug is a powder for inhalation, which should only be used with a special device - aerolayzera - which comes in the package.

Adults

In bronchial asthma dose for regular maintenance therapy - 12-24 mg (1-2 capsules content.) 2 times a day.

The drug Foradil should only be used as adjunctive therapy to inhaled corticosteroids.

Do not exceed the maximum recommended dose for adults of the drug (48 mg / day). Given that the maximum daily dose Foradil - 48 mg, if necessary, in addition can be used 12-24 mg / day for the relief of symptoms of asthma.

If you need to use additional doses of the drug ceases to be episodic (eg becoming more often than two days per week), the patient should be advised to consult a doctor for treatment review, as this may indicate a worsening of asthma.

Against the background of acute asthma should not start treatment with Foradil or change the dosage. The drug Foradil should not be used for the relief of acute asthma attacks.

In order to prevent bronchospasm caused by exercise or unavoidable exposure to a known allergen for 15 minutes before the expected exposure to the allergen or until the load should be inhaled 12 mg of the drug (the contents of 1 capsule.).

Patients with severe bronchospasm in history for the prevention of inhalation may need 2 capsules content. (24 g).

When COPD dose for regular maintenance therapy - by 12-24 g (. The contents of 1-2 capsules) 2 times a day.

Children 5 years and older

The maximum recommended dose - 24 mg / day.

In bronchial asthma dose for regular maintenance therapy - 12 mg 2 times a day. The drug Foradil should only be used as adjunctive therapy to inhaled corticosteroids.

Children from 5 to 12 years are recommended to use combination products containing inhaled corticosteroids and beta2-adrenergic agonist is a long-acting, except where the need for their independent use.

In order to prevent bronchospasm caused by exercise or unavoidable exposure to a known allergen for 15 minutes before the expected exposure to the allergen or until the load should be inhaled 12 mg of the drug (the contents of 1 capsule.).

Instructions for inhalation

In order to ensure the correct use of the drug, a physician or other health care professional should show the patient how to use the inhaler; explain to the patient that use capsules with powder for inhalation should be only through aerolayzera; warn the patient that the capsules are intended for inhalation use only and are not intended to be swallowed.

Children should use the drug under the supervision of an adult.

It is important that the patient realized that due to the destruction of gelatin capsules the gelatin in small pieces by inhalation can get into the mouth or throat. In order to reduce this phenomenon to a minimum, do not pierce the capsule 1 once more. To take out a capsule from the blister pack immediately before application (see. "Instructions for use aerolayzera"). There are anecdotal reports of patients accidentally swallowed drug capsules whole. Most of these cases are not associated with the development of adverse events. The health worker should explain to the patient how to use the drug, especially after the inhalation of the patient is not breathing comes improvement.

Elderly patients (over 65 years). Data for the need of the drug in a different dose in patients over 65 years of age compared with younger patients received.

Instructions for use

1. It is necessary to remove the cap from aerolayzera.

2. It is hard to keep aerolayzer the base and turn the mouthpiece in the direction of the arrow.

3. Place the capsule in a cell located at the base aerolayzera (it has a capsule shape). Keep in mind that removing the capsule from the blister pack should be immediately prior to inhalation.

4. Turn the mouthpiece should be closed aerolayzer.

5. Hold aerolayzer in the upright position, should press 1 again before the end of the blue button is available on each side aerolayzera. Then let them go.

Note. At this stage, by puncturing it may break the capsule, so that small pieces can fall into the gelatin, mouth or throat. Since gelatin is edible, it will not cause any harm. To the capsule is not completely destroyed, it should meet the following requirements: not to pierce the capsule more than 1 times; to comply with the storage rules; removing the capsule from the blister until immediately prior to inhalation.

6. It is necessary to make a full exhalation.

7. It is necessary to take the mouthpiece into your mouth and gently tilt the head back. Firmly grasp the mouthpiece lips and even make a quick, deep breath as much as possible. It must be a characteristic rattling sound generated by the rotation of the capsule and powder spraying. If there is no characteristic sound, it should be open aerolayzer and see what happened to the capsule. Maybe she's stuck in a cell. In this case, you need to carefully remove the capsule. In no event should not attempt to release the capsule by repeated taps on the sides of aerolayzera button.

8. If the characteristic sound originated by inhalation, you need to hold your breath as long as possible. At the same time, it should remove the mouthpiece out of his mouth. Then exhale. Open aerolayzer and see not stayed there in a capsule powder. If the capsule remained powder, re-do the steps described in paragraphs 6-8.

9. After the inhalation procedure, you must open the aerolayzer, remove the empty capsule, close mouthpiece and aerolayzer cap.

Care aerolayzerom: to remove powder residue should be wiped with a mouthpiece and a cell with a dry cloth. You can also use a soft brush.

release Form

Capsules for powder inhalation with 12 ug. The blister, 10 pcs. 3 or 6 bl. with the device for inhalation aerolayzer in a carton box.

Conditions of supply

On prescription.

Storage

In a dry place at a temperature no higher than 25 ° C.

Keep out of the reach of children.

Shelf-life

2 years.

Do not use beyond the expiration date printed on the package.